Systemic Signature of the Lung Response to Respiratory Syncytial Virus Infection
2011

Understanding the Immune Response to Respiratory Syncytial Virus Infection

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jeroen L. A. Pennings, Annemieke Schuurhof, Hennie M. Hodemaekers, Annemarie Buisman, Lia C. G. H. de Rond, Myra N. Widjojoatmodjo, Willem Luytjes, Jan L. L. Kimpen, Louis Bont, Riny Janssen

Primary Institution: National Institute for Public Health and the Environment, Bilthoven, The Netherlands

Hypothesis

Can blood diagnostics distinguish between protective and unfavorable lung responses in RSV infection?

Conclusion

The study found that blood gene signatures can indicate different immune responses to RSV infection, potentially aiding in diagnostics.

Supporting Evidence

  • 53 genes were identified that showed correlated responses in lung, lymph nodes, and blood.
  • Blood gene signatures can distinguish between acute infection and vaccine-enhanced disease.
  • Interferon signaling was a predominant process found among the functional annotations for the shared genes.

Takeaway

This study looked at how the body reacts to a virus called RSV and found that we can tell if someone is getting better or worse by looking at their blood.

Methodology

BALB/c mice were infected with RSV, and gene expression was analyzed in lung, lymph nodes, and blood over several days.

Limitations

The study was conducted in mice, which may not fully represent human responses.

Participant Demographics

BALB/c mice aged 6-10 weeks

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0021461

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication